{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:36:20Z","timestamp":1770723380551,"version":"3.49.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Nitric oxide (NO) and hydrogen sulfide (H<jats:sub>2<\/jats:sub>S) play a pivotal role in nerve-mediated relaxation of the bladder outflow region. In the bladder neck, a marked phosphodiesterase type 4 (PDE4) expression has also been described and PDE4 inhibitors, as rolipram, produce smooth muscle relaxation. This study investigates the role of PDE4 isoenzyme in bladder neck gaseous inhibitory neurotransmission. We used Western blot and double immunohistochemical staining for the detection of NPP4 (PDE4) and PDE4A and organ baths for isometric force recording to roflumilast and tadalafil, PDE4 and PDE5, respectively, inhibitors in pig and human samples. Endogenous H<jats:sub>2<\/jats:sub>S production measurement and electrical field stimulation (EFS) were also performed. A rich PDE4 and PDE4A expression was observed mainly limited to nerve fibers of the smooth muscle layer of both species. Moreover, roflumilast produced a much more potent smooth muscle relaxation than that induced by tadalafil. In porcine samples, H<jats:sub>2<\/jats:sub>S generation was diminished by H<jats:sub>2<\/jats:sub>S and NO synthase inhibition and augmented by roflumilast. Relaxations elicited by EFS were potentiated by roflumilast. These results suggest that PDE4, mainly PDE4A, is mostly located within nerve fibers of the pig and human bladder neck, where roflumilast produces a powerful smooth muscle relaxation. In pig, the fact that roflumilast increases endogenous H<jats:sub>2<\/jats:sub>S production and EFS-induced relaxations suggests a modulation of PDE4 on NO- and H<jats:sub>2<\/jats:sub>S-mediated inhibitory neurotransmission.<\/jats:p>","DOI":"10.1038\/s41598-018-22934-1","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T15:33:53Z","timestamp":1520868833000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Phosphodiesterase type 4 inhibition enhances nitric oxide- and hydrogen sulfide-mediated bladder neck inhibitory neurotransmission"],"prefix":"10.1038","volume":"8","author":[{"given":"\u00c1ngel","family":"Agis-Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paz","family":"Recio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Elvira","family":"L\u00f3pez-Oliva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Pilar","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Victoria","family":"Barahona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Benedito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"Jim\u00e9nez-Cidre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albino","family":"Garc\u00eda-Sacrist\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edtor S.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Medardo","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"22934_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1540\/jsmr.39.67","volume":"39","author":"T Matsumoto","year":"2003","unstructured":"Matsumoto, T., Kobayashi, T. & Kamata, K. Phosphodiesterases in the vascular system. J. Smooth Muscle Res. 39, 67\u201386 (2003).","journal-title":"J. Smooth Muscle Res."},{"key":"22934_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1540\/jsmr.41.1","volume":"41","author":"MA Wheeler","year":"2005","unstructured":"Wheeler, M. A., Ayyagari, R. R., Wheeler, G. L. & Weiss, R. M. Regulation of cyclic nucleotides in the urinary tract. J. Smooth Muscle Res. 41, 1\u201321 (2005).","journal-title":"J. Smooth Muscle Res."},{"key":"22934_CR3","doi-asserted-by":"publisher","first-page":"C1255","DOI":"10.1152\/ajpcell.00381.2004","volume":"288","author":"GV Petkov","year":"2005","unstructured":"Petkov, G. V. & Nelson, M. T. Differential regulation of Ca2+-activated K+ channels by beta-adrenoceptors in guinea pig urinary bladder smooth muscle. Am J Physiol Cell Physiol 288, C1255\u2013C1263 (2005).","journal-title":"Am J Physiol Cell Physiol"},{"key":"22934_CR4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.eururo.2006.10.023","volume":"51","author":"S Oger","year":"2007","unstructured":"Oger, S. et al. Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition. Eur. Urol. 51, 772\u2013780 (2007).","journal-title":"Eur. Urol."},{"key":"22934_CR5","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1464-410X.2006.06643.x","volume":"99","author":"J Nishiguchi","year":"2007","unstructured":"Nishiguchi, J. et al. Suppression of detrusor overactivity in rats with bladder outlet obstruction by a type 4 phosphodiesterase inhibitor. B.J.U. Int. 99, 680\u2013686 (2007).","journal-title":"B.J.U. Int."},{"key":"22934_CR6","doi-asserted-by":"publisher","first-page":"F1149","DOI":"10.1152\/ajprenal.00440.2007","volume":"295","author":"SM Brown","year":"2008","unstructured":"Brown, S. M. et al. Beta-adrenergic relaxation of mouse urinary bladder smooth muscle in the absence of large-conductance Ca2+-activated K+ channel. Am. J. Physiol. Renal Physiol. 295, F1149\u2013F1157 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"22934_CR7","doi-asserted-by":"publisher","first-page":"C1344","DOI":"10.1152\/ajpcell.00001.2008","volume":"295","author":"KL Hristov","year":"2008","unstructured":"Hristov, K. L. et al. Stimulation of beta3-adrenoceptors relaxes rat urinary bladder smooth muscle via activation of the large-conductance Ca2+-activated K+ channels. Am. J. Physiol. Cell. Physiol. 295, C1344\u2013C1353 (2008).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"22934_CR8","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s00120-009-1970-z","volume":"48","author":"S \u00dcckert","year":"2009","unstructured":"\u00dcckert, S. et al. Significance of phosphodiesterase isoenzymes in the control of human detrusor smooth muscle function. An immunohistochemical and functional study. Urologe A 48, 764\u2013769 (2009).","journal-title":"Urologe A"},{"key":"22934_CR9","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1002\/nau.20500","volume":"26","author":"KE Andersson","year":"2007","unstructured":"Andersson, K. E. LUTS treatment: future treatment options. Neurourol. Urodyn. 26, 934\u2013947 (2007).","journal-title":"Neurourol. Urodyn."},{"key":"22934_CR10","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/nau.20485","volume":"26","author":"KE Andersson","year":"2007","unstructured":"Andersson, K. E., \u00dcckert, S., Stief, C. & Hedlund, P. Phosphodiesterases (PDEs) and PDE inhibitors for treatment of LUTS. Neurourol. Urodyn. 26, 928\u2013933 (2007).","journal-title":"Neurourol. Urodyn."},{"key":"22934_CR11","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1464-410X.2007.07307.x","volume":"101","author":"Y Kaiho","year":"2008","unstructured":"Kaiho, Y. et al. The effects of a type 4 phosphodiesterase inhibitor and the muscarinic cholinergic antagonist tolterodine tartrate on detrusor overactivity in female rats with bladder outlet obstruction. B.J.U. Int. 101, 615\u2013620 (2008).","journal-title":"B.J.U. Int."},{"key":"22934_CR12","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/nau.20999","volume":"30","author":"KE Andersson","year":"2011","unstructured":"Andersson, K. E. et al. Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action. Neurourol. Urodyn. 30, 292\u2013301 (2011).","journal-title":"Neurourol. Urodyn."},{"key":"22934_CR13","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/j.1743-6109.2012.02718.x","volume":"9","author":"M Gacci","year":"2012","unstructured":"Gacci, M. et al. A randomized, placebo-controlled study to assess safety and efficacy of vardenafil 10 mg and tamsulosin 0.4 mg vs. tamsulosin 0.4 mg alone in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J. Sex. Med. 9, 1624\u20131633 (2012).","journal-title":"J. Sex. Med."},{"key":"22934_CR14","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/jsm.12039","volume":"10","author":"F Giuliano","year":"2013","unstructured":"Giuliano, F. et al. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study. J. Sex. Med. 10, 857\u2013865 (2013).","journal-title":"J. Sex. Med."},{"key":"22934_CR15","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.eururo.2012.09.006","volume":"63","author":"F Giuliano","year":"2013","unstructured":"Giuliano, F. et al. The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia. Eur. Urol. 63, 506\u2013516 (2013).","journal-title":"Eur. Urol."},{"key":"22934_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/iju.12008","volume":"20","author":"O Yamaguchi","year":"2013","unstructured":"Yamaguchi, O. Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action. Int. J. Urol. 20, 28\u201339 (2013).","journal-title":"Int. J. Urol."},{"key":"22934_CR17","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/nrurol.2013.101","volume":"10","author":"MS Rahnama\u2019I","year":"2013","unstructured":"Rahnama\u2019I, M. S., \u00dcckert, S., Hohnen, R. & van Koeveringe, G. A. The role of phosphodiesterases in bladder pathophysiology. Nat. Rev. Urol. 10, 414\u2013424 (2013).","journal-title":"Nat. Rev. Urol."},{"key":"22934_CR18","doi-asserted-by":"publisher","first-page":"S135","DOI":"10.1016\/j.juro.2012.11.025","volume":"189","author":"R Dmochowski","year":"2013","unstructured":"Dmochowski, R. et al. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial. J. Urol. 189, S135\u2013S140 (2013).","journal-title":"J. Urol."},{"key":"22934_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.eururo.2015.12.048","volume":"70","author":"M Gacci","year":"2016","unstructured":"Gacci, M. et al. Latest Evidence on the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Eur. Urol. 70, 124\u2013133 (2016).","journal-title":"Eur. Urol."},{"key":"22934_CR20","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/sj.bjp.0707669","volume":"153","author":"M Hern\u00e1ndez","year":"2008","unstructured":"Hern\u00e1ndez, M. et al. Role of neuronal voltage-gated K+ channels in the modulation of the nitrergic neurotransmission of the pig urinary bladder neck. Br. J. Pharmacol. 153, 1251\u20131258 (2008).","journal-title":"Br. J. Pharmacol."},{"key":"22934_CR21","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/nau.20368","volume":"26","author":"M Hern\u00e1ndez","year":"2007","unstructured":"Hern\u00e1ndez, M. et al. Pre-junctional alpha2-adrenoceptors modulation of the nitrergic transmission in the pig urinary bladder neck. Neurourol. Urodyn. 26, 578\u2013583 (2007).","journal-title":"Neurourol. Urodyn."},{"key":"22934_CR22","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neulet.2010.04.040","volume":"477","author":"S Bustamante","year":"2010","unstructured":"Bustamante, S. et al. Functional evidence of nitrergic neurotransmission in the human urinary bladder neck. Neurosci. Lett. 477, 91\u201394 (2010).","journal-title":"Neurosci. Lett."},{"key":"22934_CR23","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.juro.2013.02.103","volume":"190","author":"VS Fernandes","year":"2013","unstructured":"Fernandes, V. S. et al. Hydrogen sulfide-mediated inhibitory neurotransmission to the pig bladder neck: Role of KATP channels, sensory nerves and calcium signaling. J. Urol. 190, 746\u2013756 (2013).","journal-title":"J. Urol."},{"key":"22934_CR24","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1016\/j.juro.2012.10.006","volume":"189","author":"VS Fernandes","year":"2013","unstructured":"Fernandes, V. S. et al. Endogenous hydrogen sulfide has a powerful role in inhibitory neurotransmission to the pig bladder neck. J. Urol. 189, 1567\u20131573 (2013).","journal-title":"J. Urol."},{"key":"22934_CR25","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1111\/j.1476-5381.2009.00314.x","volume":"157","author":"M Hern\u00e1ndez","year":"2009","unstructured":"Hern\u00e1ndez, M., Knight, G. E., Wildman, S. S. & Burnstock, G. Role of ATP and related purines in inhibitory neurotransmission to the pig urinary bladder neck. Br. J. Pharmacol. 157, 1463\u20131473 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"22934_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1476-5381.2009.00144.x","volume":"157","author":"P Recio","year":"2009","unstructured":"Recio, P. et al. 5-hydroxytryptamine induced relaxation in the pig urinary bladder neck. Br. J. Pharmacol. 157, 271\u2013280 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"22934_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/sj.bjp.0706832","volume":"149","author":"M Hern\u00e1ndez","year":"2006","unstructured":"Hern\u00e1ndez, M. et al. Neuronal and smooth muscle receptors involved in the PACAP- and VIP-induced relaxations of the pig urinary bladder neck. Br. J. Pharmacol. 149, 100\u2013109 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"22934_CR28","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/nau.20287","volume":"25","author":"M Hern\u00e1ndez","year":"2006","unstructured":"Hern\u00e1ndez, M. et al. PACAP 38 is involved in the non adrenergic non cholinergic inhibitory neurotransmission in the pig urinary bladder neck. Neurourol. Urodyn. 25, 490\u2013497 (2006).","journal-title":"Neurourol. Urodyn."},{"key":"22934_CR29","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/jsm.12456","volume":"11","author":"AS Ribeiro","year":"2014","unstructured":"Ribeiro, A. S. et al. Powerful relaxation of phosphodiesterase type 4 inhibitor rolipram in the pig and human bladder neck. J. Sex. Med. 11, 930\u2013941 (2014).","journal-title":"J. Sex. Med."},{"key":"22934_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.pupt.2005.09.002","volume":"19","author":"L Wollin","year":"2006","unstructured":"Wollin, L., Bundschuh, D. S., Wohlsen, A., Marx, D. & Beume, R. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors. Pulm. Pharmacol. Ther. 19, 343\u2013352 (2006).","journal-title":"Pulm. Pharmacol. Ther."},{"key":"22934_CR31","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1111\/bph.13512","volume":"173","author":"R Venkatasamy","year":"2016","unstructured":"Venkatasamy, R. & Spina, D. Novel relaxant effects of RPL554 on guinea pig tracheal smooth muscle contractility. Br. J. Pharmacol. 173, 2335\u20132351 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"22934_CR32","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jaci.2015.11.035","volume":"138","author":"ED Bateman","year":"2016","unstructured":"Bateman, E. D., Goehring, U. M., Richard, F. & Watz, H. Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma. J. Allergy Clin. Immunol. 138, 142\u2013149 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"22934_CR33","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.2147\/COPD.S106370","volume":"11","author":"L Yuan","year":"2016","unstructured":"Yuan, L., Dai, X., Yang, M., Cai, Q. & Shao, N. Potential treatment benefits and safety of roflumilast in COPD: a systematic review and meta-analysis. Int. J. Chron. Obstruct. Pulmon. Dis. 11, 1477\u20131483 (2016).","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"22934_CR34","doi-asserted-by":"publisher","first-page":"515.e8","DOI":"10.1016\/j.urology.2010.04.035","volume":"76","author":"E Waldkirch","year":"2010","unstructured":"Waldkirch, E. et al. Expression of cAMP-dependent protein kinase isoforms in the human prostate: functional significance and relation to PDE4. Urology 76, 515.e8\u201314 (2010).","journal-title":"Urology"},{"key":"22934_CR35","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ejphar.2014.08.005","volume":"741","author":"GT Kedia","year":"2014","unstructured":"Kedia, G. T. et al. Phosphodiesterase isoenzymes in the human urethra: a molecular biology and functional study. Eur. J. Pharmacol. 741, 330\u2013335 (2014).","journal-title":"Eur. J. Pharmacol."},{"key":"22934_CR36","doi-asserted-by":"publisher","first-page":"964.e1","DOI":"10.1016\/j.urology.2014.12.030","volume":"85","author":"GT Kedia","year":"2015","unstructured":"Kedia, G. T. et al. Expression and distribution of phosphodiesterase isoenzymes in the human male urethra. Urology 85, 964.e1\u20136 (2015).","journal-title":"Urology"},{"key":"22934_CR37","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1111\/j.1743-6109.2011.02397.x","volume":"8","author":"S \u00dcckert","year":"2011","unstructured":"\u00dcckert, S. et al. Expression and distribution of phosphodiesterase isoenzymes in the human seminal vesicles. J. Sex. Med. 8, 3058\u20133065 (2011).","journal-title":"J. Sex. Med."},{"key":"22934_CR38","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.eururo.2012.07.025","volume":"62","author":"F Fusco","year":"2012","unstructured":"Fusco, F. et al. Sildenafil effect on the human bladder involves the L-cysteine\/hydrogen sulfide pathway: a novel mechanism of action of phosphodiesterase type 5 inhibitors. Eur. Urol. 62, 1174\u20131180 (2012).","journal-title":"Eur. Urol."},{"key":"22934_CR39","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1111\/j.1743-6109.2012.02821.x","volume":"9","author":"J Angulo","year":"2012","unstructured":"Angulo, J. et al. Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck. J. Sex. Med. 9, 2293\u20132306 (2012).","journal-title":"J. Sex. Med."},{"key":"22934_CR40","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1476-5381.1993.tb13641.x","volume":"109","author":"Y Qian","year":"1993","unstructured":"Qian, Y., Naline, E., Karlsson, J. A., Raeburn, D. & Advenier, C. Effects of rolipram and siguazodan on the human isolated bronchus and their interaction with isoprenaline and sodium nitroprusside. Br. J. Pharmacol. 109, 774\u2013778 (1993).","journal-title":"Br. J. Pharmacol."},{"key":"22934_CR41","doi-asserted-by":"publisher","first-page":"L396","DOI":"10.1152\/ajplung.00125.2013","volume":"305","author":"EA Townsend","year":"2013","unstructured":"Townsend, E. A. & Emala, C. W. Sr. Quercetin acutely relaxes airway smooth muscle and potentiates \u03b2-agonist-induced relaxation via dual phosphodiesterase inhibition of PLC\u03b2 and PDE4. Am. J. Physiol. Lung Cell. Mol. Physiol. 305, L396\u2013L403 (2013).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"22934_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ejphar.2008.02.022","volume":"586","author":"HS B\u00fcy\u00fcknacar","year":"2008","unstructured":"B\u00fcy\u00fcknacar, H. S., Kumcu, E. K., G\u00f6\u00e7men, C. & Onder, S. Effect of phosphodiesterase type 4 inhibitor rolipram on cyclophosphamide-induced cystitis in rats. Eur. J. Pharmacol. 586, 293\u2013299 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"22934_CR43","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1111\/j.1464-410X.2008.07662.x","volume":"102","author":"T Kitta","year":"2008","unstructured":"Kitta, T., Tanaka, H., Mitsui, T., Moriya, K. & Nonomura, K. Type 4 phosphodiesterase inhibitor suppresses experimental bladder inflammation. B.J.U. Int. 102, 1472\u20131476 (2008).","journal-title":"B.J.U. Int."},{"key":"22934_CR44","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1464-410X.2008.07948.x","volume":"103","author":"M Sakura","year":"2009","unstructured":"Sakura, M. et al. Rolipram, a specific type-4 phosphodiesterase inhibitor, inhibits cyclophosphamide-induced haemorrhagic cystitis in rats. B.J.U. Int. 103, 264\u2013269 (2009).","journal-title":"B.J.U. Int."},{"key":"22934_CR45","doi-asserted-by":"publisher","first-page":"12107","DOI":"10.3390\/ijms140612107","volume":"14","author":"K Li","year":"2013","unstructured":"Li, K. et al. Eviprostat activates cAMP signaling pathway and suppresses bladder smooth muscle cell proliferation. Int. J. Mol. Sci. 14, 12107\u201312122 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"22934_CR46","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1096\/fj.04-3583fje","volume":"19","author":"L Li","year":"2005","unstructured":"Li, L. et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J. 19, 1196\u20131198 (2005).","journal-title":"FASEB J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22934-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22934-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22934-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T23:20:16Z","timestamp":1719876016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22934-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,16]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["22934"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-22934-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,16]]},"assertion":[{"value":"18 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"4711"}}